ArticleCancer science2022

Parsaclisib in Japanese patients with relapsed or refractory B-cell lymphoma (CITADEL-111): A phase Ib study.

Noriko Fukuhara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.